Preparation of 91 kDa ascitic protein and its antibody Ascitic fluid used was obtained from a patient with a malignant ovarian and uterine tumour (mixed mesodermal tumour) at the time of paracentesis, and then centrifuged at 5,000 rpm for 30 min at 4°C. The supernatant was kept at -20°C until use.
An ectopic developmental antigen that appears in malignant ascitic fluid was separated by a new procedure involving DEAE-Sepharose chromatography as described in the previous paper. 25) In brief, pooled ascitic fluid was treated as follow: (1) immunoglobulins were removed using polyethylene glycol 4,000 fractionation; (2) the peak, on DEAESepharose chromatography at pH 6.6, showing the highest specific reactivity to the "First-Generation" antiserum21)22) was collected; (3) the protein was separated by a preparative-polyacrylamide gel electrophoresis (PAGE); (4) the antibody against the protein was generated in rabbits; (5) the antibody was applied to a column of normal human plasma (NHP)-coupled Sepharose 4B, then, the "SecondGeneration" antibody was obtained within the unbound fractions; (6) a molecular size of the protein was confirmed to be 91 kDa by SDS-PAGE; (7) the monospecificity of the antibody was found using a SDS-PAGE-`SRID' technique.
In this study, the antibody obtained was used for revealing immunocytochemical characterization of the protein in the human placenta.
Tissue preparation
Thirty-eight placentas were obtained from healthy women at between the 7th and 42nd week of gestation (14 at 7-10 weeks; 15 at 11-20 weeks; 9 at 37-42 weeks at term). Small pieces (1 mm3) of villous tissue were excised and fixed by immersion at 4°C for 4-6 h in Zamboni's fixative with a minor modification9'34), and then processed through graded changes of ethanol and xylene, and embedded in paraffin wax.
Immunocytochemical procedures
All immunocytochemical procedures were carried out at room temperature. Deparaffinized sections kept in 0.01 M phosphate-buffered saline (PBS), pH 7.3, were subjected to the following protocol: (1) enzymatic digestion with 0.1% (w/v) pepsin in 0.05 M Tris-HCI buffer, pH 7.6, containing 0.1% (wlv) CaCl2, 30 min at 37°C; (2) 3 washes with PBS, 5 min each; (3) blocking of endogenous peroxidase activity with 5 mM sodium metaperiodate solution, 10 min; (4) 3 washes with PBS, 5 min each; (5) blocking freealdehyde groups with 3 mM sodium borohydride solution, 10 min; (6) 3 washes with PBS, 5 min each; (7) pre-treatment with highly diluted (1:2,500) normal goat serum, 30 min; (8) incubation with the specific antibody diluted at 1:400 to 1:2,000 with PBSA (PBS containing 0.5% bovine serum albumin), 2-411; (9) 3 washes with PBS, 10 min each; (10) incubation with biotin-labelled goat anti-rabbit IgG, 30 min; (11) 3 washes with PBS, 10 min each; (12) incubation with avidin-biotin-HRP complex, 30 min; (13) 3 washes with PBS, 10 min each.
In the final step, sections were incubated for 2-5 min in 0.05 M Tris-HC1 buffer, pH 7.4, contaming 0.02% (w/v) 3 ,3'-diaminobenzidine tetrahydrochloride and 0.001% (v/v) hydrogen peroxide, and counterstained with 0.1% (w/v) Methyl Green in barbitone buffer at pH 4.0 for 1 h or with Mayer's Haematoxylin for 10 min.
Immunofluorescence antibody procedures followed the above-described protocol except that avidinbiotin-HRP complex was substituted with avidinbiotin-FITC complex.
In order to confirm the specificity of labellings, two concurrent control experiments were performed: (a) preimmune rabbit serum used in place of the specific antibody, and (b) avidin-biotin-HRP complex or avidin-biotin-FITC complex alone, omitting biotin-labelled goat anti-rabbit IgG to identify any non-specific adsorption of the complex.
Results
Human placentae subjected are divided into three groups by their gestational periods; the first (7-10 weeks), second (11-20 weeks) and third (term) trimesters. Figures 1-3 and Table 1 are representative of immunomicroscopical stainings most commonly seen in human placental tissues and their summarized conclusions, respectively. In the control experiments, a specific staining was never observed when a preimmune rabbit serum was used. Neither endogenous peroxidase activity nor autofluorescence was detected.
In the first trimester, the affinity-purified antibody frequently exhibited specific immunostainings to be in close association with stroma of the secondary and tertiary villi; fibrous networks, fibroblasts and the Hofbauer cells (Figs. 1-A -1-C) . The distribution of immunoreactive terminal villi was not uniform; some were positive whereas the rests were negative. Labellings in villous stroma were completely disappeared during the second trimester. A few immunogenic dot-structures were also simultaneously localized near apical regions of syncytiotrophoblasts. The population of these structures gradually increased as gestation progressed. In contrast, immunoreactive evidences were recognized in macrophage-like cells of the stroma in the secondary and tertiary stem chorionic villi (Fig. 1-D) . So far, however, the immunostaining was never seen in the umbilical cord.
In the second trimester, immunostainings were demonstrated within a numerous vesicle located in the apical part of syncytiotrophoblasts, although no evidence was seen in the cytotrophoblast (Figs. 2-A -2-E). The content of immunoreactive vesicles rapidly increased with gestational stages, reaching a maximum around 17 weeks, and then gradually reduced towards a term. The foetal blood vessel also showed positive reactions during the later-half of the second trimester; the lumen of blood vessels and endothelial cells (Figs. 2-C and 2-D) . Occasionally, around the latter half of the second trimester, a small number of dot-structures which presented by an immunofluorescence technique were associated with the basement membrane (Fig. 2-F) .
At term, the major localization of the protein was shown in the foetal blood vessels including endothelial cells (Figs. 3-A 3-D) . Intensity of the immunostaining was distinctly higher than that obtained in the second trimester. In contrast, a very few dot-structures demonstrated by immunostainings were only just detected in epithelial folds faced to the maternal space of flattened syncytiotrophoblasts.
Discussion
A novel pregnancy-associated protein with a mol- During the second trimester, the present data clearly demonstrates that a numerous small vesicle with antigenicity were determined in the apical part of syncytiotrophoblasts. The Hofbauer cell represents as an immunoreactive cell population. However, these vesicles of trophoblastic layers and cytoplasmic contents of the Hofbauer cell rapidly reduced by the end of the second trimester. On the contrary, during the course of placentation, the protein is simultaneously characterized by increased accumulation in villous capillaries. Occasionally, immunostainings of dot-structures localized along the basement membrane could be detected. It is postulated that a dynamic permeable transportation of the protein should happen across the membrane until the physiological maturation of placental barrier. This is supported by facts of a high level of the protein found in the maternal blood during the second trimester. 23, 24, 26) At term, the protein is predominantly observed in the villous blood vessels including endothelial cells. This may be reflected that transplacental permeability of the protein to the maternal blood was resisted by the placental barrier in the later-half period of second trimester.2-23) It is worth mentioning as a hypothesis that 91 kDa ascitic protein would be a strong candidate of the marker for characterizing the maturity of villous stroma and placental barrier.
So far, however, little is known of the genuine source of this protein. One would expect the protein should be derived from the extraembryonic mesodermal cells of the stem villi during early-placentation stages. However, further detailed studies are needed in order to obtain precise data in relation to the immunoreactive body which was detected in the foetoplacental circulation at term. Studies with an ultramicroscopical characterization using immunocytochemical techniques are now in progress. 
